In a bipartisan spending agreement that was largely negotiated behind closed doors, Congress included a policy change with ...

Illinois is facing an intense battle over a federal program requiring drug manufacturers to sell deeply discounted ...

Under a proposed pilot program, clinics and hospitals would pay full wholesale price, then request an after-purchase rebate.

Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under ...

The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have ...

TOPEKA — House Speaker Dan Hawkins intensified frustration among Republicans and Democrats by taking new steps to block ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

On March 17, 2026, the Ninth Circuit issued a unanimous decision in United States ex rel. Adventist Health Sys. of W. v. AbbVie Inc. allowing a ...

If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...

The drug discount program is under scrutiny on a variety of fronts ...

Kansas House Speaker Dan Hawkins abruptly sent lawmakers home to block discussion on a drug pricing bill. What lawmakers are ...